POINT BIOPHARMA GLOBAL INC.
CIK 0001811764
Revenue (TTM)
$17.11M
Q3 Nov 2023
Net Income (TTM)
−$90.73M
+314.1% YoY
Q3 Nov 2023
EPS Diluted (TTM)
−$0.89
+264.5% YoY
Q3 Nov 2023
Gross Margin
—
Q3 Nov 2023
Operating Margin
-632.4%
Q3 Nov 2023
Net Margin
-530.2%
Q3 Nov 2023
Free Cash Flow (TTM)
−$56.63M
Q3 Nov 2023
Cash
$21.61M
Q3 Nov 2023
Total Debt
—
Q3 Nov 2023
Shares Outstanding
106.57M sh
Q3 Nov 2023
Revenue & Net Income
EPS (Diluted)
Margins
Cash Flow
Revenue Growth (YoY)
No data available for this metric.